- Published at
- by manilatimes.net
positive
positive
News for Curative Biotechnology, Inc. (CUBT)
- Published at
- by globenewswire.com
mixedmixedCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the...- Published at
- by globenewswire.com
mixedmixedCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...- Published at
- by globenewswire.com
mixedmixedCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan....- Published at
- by globenewswire.com
positivepositiveCurative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023...- Published at
- by globenewswire.com
mixedmixedCurative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC:...- Published at
- by globenewswire.com
positivepositiveCurative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative...- Published at
- by marketwatch.com
mixedmixedTXO Energy going public as IPO market perks up with mostly tiny deals
With $100 million in estimated proceeds, TXO Energy is the largest initial public offering on the calendar in a busy week of eight mostly smaller deals.- Published at
- by asiaone.com
positivepositiveCurative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study GlobeNewswire January 05, 2023 Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that...- Published at
- by seekingalpha.com
mixedmixed- Published at
- by seekingalpha.com
mixedmixedCurative Biotechnology refiles for NYSE uplisting, $8M offering (OTCMKTS:CUBT)
Drug developer Curative Biotechnology (CUBT) has refiled its application to uplist to NYSE and conduct an $8M public offering after withdrawing its filing in late October. Read more here.